InvestorsHub Logo
Followers 21
Posts 1596
Boards Moderated 1
Alias Born 09/16/2008

Re: RULiquid post# 646102

Sunday, 05/15/2011 7:49:22 PM

Sunday, May 15, 2011 7:49:22 PM

Post# of 2339569
BMTI BioMimetic Therapeutics, Inc is oversold. Looking for a nice bounce. FDA panel voted favorably for Augment. Price target is $35 + as BMTI moves closer towards FDA approval. Possible buyout / takeover candidate, imo.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.